TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/18/05 16:59 | 4/14/05 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Castaldi David L | FL | D | M.d | 46 | 6.19 | 9 | 8 | 17 | 52 | D | 67 | -38 | -20 | -16 | -12 | -16 | -18 | -14 | 4 | 6 | 9 | 39 | 12 | -47 | |
6/15/04 16:14 | 6/11/04 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Castaldi David L | FL | D | M.d | 37 | 4.88 | 7 | 8 | 20 | 45 | D | 151 | 98 | 41 | -10 | -11 | -13 | -14 | -11 | 3 | -7 | -16 | -21 | -4 | -14 | |
2/19/04 12:47 | 2/17/04 | NABI | Nabi Biopharmaceuticals | DE | Health | BioPrd | Biological Products, (No Diag | Castaldi David L | MA | D | M.d | 21 | 2.81 | 12 | 8 | 25 | 37 | D | 160 | 184 | 175 | 31 | 4 | -9 | -3 | -3 | -3 | -4 | 8 | 12 | -28 | -12 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |